[Nonspecific immunotherapy with BCG vaccine in bladder tumors].

Clinical experience is recorded and summarized with the application of BCG vaccine for prophylaxis, treatment and immunochemotherapy of bladder tumors for the period June 1985-January 1988. Included in the study were 85 patients distributed in five groups: 23 patients treated for prevention of relapses; 26 treated for existing and residual surface tumors; 13 in whom BCG vaccine F-70 was applied for prophylaxis purpose; 17 with surface tumors treated only surgically--control group; 10 patients with advanced bladder tumor treated with immunochemotherapeutic agents. Once the results have been reported and discussed, the following inferences were made: 1.

[Lord's operation in the treatment of idiopathic hydrocele].

In spite of observing the requirements for thorough hemostasis and minimal trauma, the routine methods applied so far for treatment of idiopathic hydrocele have shown high percentage of postoperative complications. In a search for a more reliable and atraumatic operative method, since November 1988 the authors have performed operative treatment in 14 patients by the method of Lord. The operative technique is presented and the first results reported.